Research

Hormonal

Intensive glycemic therapy in Type 1 Diabetes produces a 'metabolic memory' effect, where the initial intensive treatment continues to reduce the risk of complications for years even after glycemic separation between treatment groups disappears.

Even if your blood sugar levels aren't perfect now, getting them under control early in your Type 1 Diabetes journey has long-lasting benefits. This 'metabolic memory' means that your body continues to benefit from early intensive treatment, reducing your risk of heart disease and other complications for decades, even if your glucose levels later become less distinct from those who had less intensive treatment.

StrongSupportsVERY_HIGH confidence
EDIC showed a durable effect of initial assigned therapies despite a loss of the glycemic separation (metabolic memory) and demonstrated that the reduction in early-stage complications during the DCCT translated into substantial reductions in severe complications and CVD.
David M. Nathan · Diabetes Care · 2013

Why this rating

Based on the same high-quality DCCT/EDIC data.

Source

The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview

David M. Nathan · Diabetes Care · 2013

DOI 10.2337/dc13-2112

rct · n=1441Cited 1,810×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →